In this chapter measures are described that should be taken to ensure the reliability and accuracy of one‐stage assays of Factor VIII coagulant activity (VIII:C). The first part deals with requirements for reagents, test conditions and procedure. The second half is dedicated to the problem of interlaboratory variation of Factor VIII assays; the results of a multicentre collaborative study on the quality control of Factor VIII concentrates are presented.
No takes yet. Share an insight, caveat, or question.
J Over (1984) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: